Noteworthy, it has been found that human epidermal growth factor‐2 (HER‐2)‐positive breast tumours display upregulation of sarcosine metabolism‐related enzymes (GNMT, SARDH, PIPOX) (Yoon et al., 2014). This evidence concerns the gene ERBB2 and breast neoplasm.